Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:03:49 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:KPTI - KARYOPHARM THERAPEUTICS INC - https://www.karyopharm.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
KPTI - Q2.06.00·7.590.16.26+0.172.8520.63,1133,3496.22  6.6596  6.0010.38  3.5118:47:13Feb 0515 min RT 2¢

Recent Trades - Last 10 of 3349
Time ETExPriceChangeVolume
18:47:13Q6.20970.119734
18:18:38Q6.150.061
16:10:04Q6.260.171
16:10:04Q6.260.171
16:05:24Q6.240.151
16:04:35Q6.260.171
16:04:30Q6.260.171
16:04:17Q6.260.171
16:04:14Q6.260.171
16:00:16Q6.260.171,456

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 07:30U:KPTINews ReleaseKaryopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
2026-02-02 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-01-12 07:00U:KPTINews ReleaseKaryopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
2026-01-02 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-08 07:00U:KPTINews ReleaseKaryopharm to Participate in Baird's Biotech Discovery Series
2025-12-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-01 07:00U:KPTINews ReleaseKaryopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference
2025-11-03 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-11-03 07:00U:KPTINews ReleaseKaryopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
2025-10-27 07:00U:KPTINews ReleaseKaryopharm to Report Third Quarter 2025 Financial Results on November 3, 2025
2025-10-08 07:00U:KPTINews ReleaseKaryopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
2025-10-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-09-10 07:00U:KPTINews ReleaseKaryopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
2025-09-02 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-08-11 07:30U:KPTINews ReleaseKaryopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress
2025-08-05 07:00U:KPTINews ReleaseKaryopharm to Report Second Quarter 2025 Financial Results on August 11, 2025
2025-08-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-07-01 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-06-03 08:00U:KPTINews ReleaseKaryopharm to Present at the Jefferies Global Healthcare Conference
2025-06-02 16:05U:KPTINews ReleaseKaryopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)